SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-030796
Filing Date
2023-05-18
Accepted
2023-05-18 18:31:30
Documents
1
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7240
  Complete submission text file 0001209191-23-030796.txt   8581
Mailing Address 3338 LANCASHIRE RD FURLONG PA 18925
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 23937460

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations